Paraneoplastic myopathy

Research output: Article

31 Citations (Scopus)

Abstract

Cancer-associated myositis differs from primary myositis in many aspects. Prognosis and life-expectancy are determined by the underlying malignancy. Therefore, patient-specific examinations for detection of an underlying cancer are important in the management of patients. Recent clinical findings and new possibilities in immunoserological testing may result in the elaboration of an evidence-based recommendation for cancer screening programs in patients with IIM in the future.

Original languageEnglish
Pages (from-to)594-598
Number of pages5
JournalCurrent Opinion in Rheumatology
Volume21
Issue number6
DOIs
Publication statusPublished - nov. 2009

Fingerprint

Muscular Diseases
Myositis
Neoplasms
Life Expectancy
Early Detection of Cancer

ASJC Scopus subject areas

  • Rheumatology

Cite this

Paraneoplastic myopathy. / Dankó, K.; Ponyi, A.; Molnar, Andrew P.; András, C.; Constantin, T.

In: Current Opinion in Rheumatology, Vol. 21, No. 6, 11.2009, p. 594-598.

Research output: Article

@article{d7f963dac3de4a278ed28849559eafcd,
title = "Paraneoplastic myopathy",
abstract = "Cancer-associated myositis differs from primary myositis in many aspects. Prognosis and life-expectancy are determined by the underlying malignancy. Therefore, patient-specific examinations for detection of an underlying cancer are important in the management of patients. Recent clinical findings and new possibilities in immunoserological testing may result in the elaboration of an evidence-based recommendation for cancer screening programs in patients with IIM in the future.",
keywords = "Cancer-associated myositis, Dermatomyositis, Paraneoplastic myopathy, Polymyositis, Prognostic signs",
author = "K. Dank{\'o} and A. Ponyi and Molnar, {Andrew P.} and C. Andr{\'a}s and T. Constantin",
year = "2009",
month = "11",
doi = "10.1097/BOR.0b013e3283317fa5",
language = "English",
volume = "21",
pages = "594--598",
journal = "Current Opinion in Rheumatology",
issn = "1040-8711",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Paraneoplastic myopathy

AU - Dankó, K.

AU - Ponyi, A.

AU - Molnar, Andrew P.

AU - András, C.

AU - Constantin, T.

PY - 2009/11

Y1 - 2009/11

N2 - Cancer-associated myositis differs from primary myositis in many aspects. Prognosis and life-expectancy are determined by the underlying malignancy. Therefore, patient-specific examinations for detection of an underlying cancer are important in the management of patients. Recent clinical findings and new possibilities in immunoserological testing may result in the elaboration of an evidence-based recommendation for cancer screening programs in patients with IIM in the future.

AB - Cancer-associated myositis differs from primary myositis in many aspects. Prognosis and life-expectancy are determined by the underlying malignancy. Therefore, patient-specific examinations for detection of an underlying cancer are important in the management of patients. Recent clinical findings and new possibilities in immunoserological testing may result in the elaboration of an evidence-based recommendation for cancer screening programs in patients with IIM in the future.

KW - Cancer-associated myositis

KW - Dermatomyositis

KW - Paraneoplastic myopathy

KW - Polymyositis

KW - Prognostic signs

UR - http://www.scopus.com/inward/record.url?scp=70349817087&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349817087&partnerID=8YFLogxK

U2 - 10.1097/BOR.0b013e3283317fa5

DO - 10.1097/BOR.0b013e3283317fa5

M3 - Article

C2 - 19730376

AN - SCOPUS:70349817087

VL - 21

SP - 594

EP - 598

JO - Current Opinion in Rheumatology

JF - Current Opinion in Rheumatology

SN - 1040-8711

IS - 6

ER -